This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business Annual General Meeting

Evotec 2026 AGM Elects New Board

Analysis based on 8 articles · First reported Jun 11, 2026 · Last updated Jun 11, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market impact on Evotec is generally neutral to slightly positive, as the company successfully conducted its Annual General Meeting and made changes to its Supervisory Board leadership. This demonstrates stable corporate governance, which can reassure investors.

Biotechnology Pharmaceuticals

Evotec SE held its Annual General Meeting on June 11, 2026, where all agenda items were adopted by shareholders. Key outcomes included the election of Dieter Weinand and Dr. Wolfgang Hofmann to the Supervisory Board. Following the meeting, the Supervisory Board appointed Dieter Weinand as its new Chairman, succeeding Prof. Dr. Iris Low-Friedrich. Additionally, Dr. Duncan McHale and Wesley Wheeler were re-elected to the Supervisory Board. The meeting saw 43.10% of Evotec's registered share capital represented.

stock
Evotec held its Annual General Meeting, where shareholders adopted all agenda items and elected new members to its Supervisory Board, including a new Chairman. This event impacts Evotec's corporate governance and strategic direction.
Importance 100.0 Sentiment 10.0
per
Dieter Weinand was newly elected to the Supervisory Board of Evotec and subsequently appointed as its Chairman, succeeding Prof. Dr. Iris Low-Friedrich. This signifies a change in leadership for the Supervisory Board.
Importance 80.0 Sentiment 20.0
per
Dr. Wolfgang Hofmann was newly elected to the Supervisory Board of Evotec.
Importance 60.0 Sentiment 10.0
per
Dr. Duncan McHale was re-elected to the Supervisory Board of Evotec.
Importance 40.0 Sentiment 5.0
per
Wesley Wheeler was re-elected to the Supervisory Board of Evotec.
Importance 40.0 Sentiment 5.0
per
Prof. Dr. Iris Low-Friedrich was succeeded by Dieter Weinand as Chairman of the Supervisory Board of Evotec.
Importance 30.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.